Bevacizumab Solution For Infusion

Bevacizumab Solution For Infusion Specification

Origin of Medicine
India

Drug Type
Injection

Physical Form
Liquid

Dosage
400mg

Dosage Guidelines
As per doc. suggestion

Storage Instructions
Dry & Cool place

Bevacizumab Solution For Infusion Trade Information

Minimum Order Quantity
10 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Bevacizumab Solution For Infusion

Bevacizumab Solution For Infusion is a liquid drug type injection that contains 400mg of the active ingredient. It is an effective medication for various types of cancer treatment that works by blocking the development of blood vessels in tumors that can inhibit their growth. This product is manufactured in India and should be stored in a dry and cool place, away from direct sunlight. The dosage of this solution should be administered as per the doctors suggestion.

FAQs of Bevacizumab Solution For Infusion:

Q: What is Bevacizumab Solution For Infusion used for?

A: Bevacizumab Solution For Infusion is used to treat various types of cancer, such as colorectal cancer, lung cancer, and breast cancer.

Q: What is the dosage of this solution?

A: The dosage of this solution should be administered as per the doctors suggestion, which is usually based on the patients medical condition and response to the treatment.

Q: How should the solution be stored?

A: The solution should be stored in a dry and cool place, away from direct sunlight.

Q: What are the side effects of this medication?

A: Some common side effects of Bevacizumab Solution For Infusion include headache, nausea, vomiting, diarrhea, and high blood pressure. However, not everyone experiences these side effects, and they may vary from person to person.

Q: Who can use Bevacizumab Solution For Infusion?

A: Bevacizumab Solution For Infusion should only be used under the supervision of a healthcare professional and is not recommended for pregnant or breastfeeding women or patients with a history of bleeding disorders.

Tell us about your requirement